Research on lung NETs is ongoing, focusing on understanding the molecular biology of these tumors, improving diagnostic methods, and developing new treatments. Clinical trials are investigating novel therapies, including immunotherapies and personalized medicine approaches, aiming to improve outcomes for patients with advanced disease.
